FDA Approved: VALCYTE — Supplemental Application (H2-Pharma, LLC)

View source ↗

Summary

The FDA approved a supplemental application for VALCYTE (valganciclovir) submitted by H2-Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegaloviral Retinitis
• Cytomegalovirus Infection

Drugs mentioned

• Valcyte (valganciclovir)

Snippet

SUPPL AP for VALCYTE (VALGANCICLOVIR)